KALV filings
Corporate insider profile
Christopher Yea Filing Activity
Latest reported as CHIEF DEVELOPMENT OFFICER of KalVista Pharmaceuticals, Inc. (KALV).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$1,050,677.69
- Latest transaction
- May 27, 2026
Affiliated corporations
Reported company relationships
Transaction history
